speb/financial-data huggingface dataset:
OGE cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 7600000.00
OGE cash_flow (quarterly, 2026-03-31) — Deferred Tax: 7600000.00
OGE cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 136400000.00
OGE income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 136400000.00
OGE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 136400000.00
OGE income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 136400000.00
OGE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 207200000.00
OGE income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.24
OGE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 50200000.00
OGE balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 87700000.00
OGE income_statement (quarterly, 2026-03-31) — EBIT: 119300000.00
OGE income_statement (quarterly, 2026-03-31) — EBITDA: 255700000.00
OGE balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 153100000.00
OGE cash_flow (quarterly, 2026-03-31) — End Cash Position: 200000.00
OGE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 107800000.00
OGE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -91300000.00
OGE balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -2600000.00
OGE balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 309200000.00
OGE balance_sheet (quarterly, 2026-03-31) — Gross PPE: 18282700000.00
OGE income_statement (quarterly, 2026-03-31) — Gross Profit: 279400000.00
OGE income_statement (quarterly, 2026-03-31) — Interest Expense: 59900000.00
OGE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 59900000.00
OGE balance_sheet (quarterly, 2026-03-31) — Interest Payable: 82600000.00
OGE balance_sheet (quarterly, 2026-03-31) — Inventory: 321700000.00
OGE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 10801200000.00
OGE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -283300000.00
OGE cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 2700000.00
OGE cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 200400000.00
OGE balance_sheet (quarterly, 2026-03-31) — Line Of Credit: 492400000.00
OGE balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 5369600000.00
OGE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 5369600000.00
OGE cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
OGE cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -600000.00
OGE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 2700000.00
OGE balance_sheet (quarterly, 2026-03-31) — Net Debt: 5861800000.00
OGE income_statement (quarterly, 2026-03-31) — Net Income: 50200000.00
OGE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 50200000.00
OGE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 50200000.00
OGE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 50200000.00
OGE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 50200000.00
OGE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 50200000.00
OGE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 50200000.00
OGE income_statement (quarterly, 2026-03-31) — Net Interest Income: -59900000.00
OGE cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 199800000.00
OGE cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -600000.00
OGE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -59900000.00
OGE cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -16500000.00
OGE balance_sheet (quarterly, 2026-03-31) — Net PPE: 13039600000.00
OGE cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 200400000.00
OGE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 4939200000.00
OGE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 1520800000.00
OGE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1520800000.00
OGE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 248200000.00
OGE income_statement (quarterly, 2026-03-31) — Normalized Income: 43861616.16
OGE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 175500000.00
OGE income_statement (quarterly, 2026-03-31) — Operating Income: 113100000.00
OGE income_statement (quarterly, 2026-03-31) — Operating Revenue: 736700000.00
OGE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 206374321.00
OGE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 78200000.00
OGE balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 94800000.00
OGE balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -2600000.00
OGE income_statement (quarterly, 2026-03-31) — Other Income Expense: 6200000.00
OGE balance_sheet (quarterly, 2026-03-31) — Other Inventories: 108800000.00
OGE cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -30400000.00
OGE balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 68100000.00
OGE balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 315600000.00
OGE income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -1300000.00
OGE balance_sheet (quarterly, 2026-03-31) — Other Properties: 128800000.00
OGE income_statement (quarterly, 2026-03-31) — Other Special Charges: -7500000.00
OGE income_statement (quarterly, 2026-03-31) — Other Taxes: 29900000.00
OGE balance_sheet (quarterly, 2026-03-31) — Payables: 403400000.00
OGE balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 486000000.00
OGE balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 33400000.00
OGE income_statement (quarterly, 2026-03-31) — Pretax Income: 59400000.00
OGE cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: -5600000.00
OGE balance_sheet (quarterly, 2026-03-31) — Receivables: 408400000.00
OGE income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 473200000.00
OGE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 136400000.00
OGE cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -600000.00
OGE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 3562500000.00
OGE balance_sheet (quarterly, 2026-03-31) — Share Issued: 206374321.00
OGE cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 200400000.00
OGE income_statement (quarterly, 2026-03-31) — Special Income Charges: 7500000.00
OGE cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 3800000.00
OGE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 4939200000.00
OGE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 4939200000.00
OGE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 1161616.16
OGE income_statement (quarterly, 2026-03-31) — Tax Provision: 9200000.00
OGE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.15
OGE balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 35700000.00
OGE balance_sheet (quarterly, 2026-03-31) — Total Assets: 14472100000.00
OGE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 10308800000.00
OGE balance_sheet (quarterly, 2026-03-31) — Total Debt: 5862000000.00
OGE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 4939200000.00
OGE income_statement (quarterly, 2026-03-31) — Total Expenses: 639500000.00
OGE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 9532900000.00
OGE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 13663600000.00
OGE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 8301000000.00
OGE income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 113100000.00
OGE balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 32800000.00
OGE income_statement (quarterly, 2026-03-31) — Total Unusual Items: 7500000.00
OGE income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 7500000.00
OGE balance_sheet (quarterly, 2026-03-31) — Working Capital: -423400000.00
OGEN balance_sheet (annual, 2021-12-31) — Accounts Payable: 854983.00
OGEN balance_sheet (annual, 2021-12-31) — Accumulated Depreciation: -1626796.00
OGEN cash_flow (annual, 2021-12-31) — Capital Expenditure: -43876.00
OGEN balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 493790.00
OGEN cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Investing Activities: -43876.00
OGEN balance_sheet (annual, 2021-12-31) — Current Accrued Expenses: 34860.00
OGEN balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 194270.00
OGEN cash_flow (annual, 2021-12-31) — Depreciation Amortization Depletion: 41237.00
OGEN cash_flow (annual, 2021-12-31) — Depreciation And Amortization: 41237.00
OGEN cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 0.00
OGEN balance_sheet (annual, 2021-12-31) — Gross PPE: 2150386.00
OGEN cash_flow (annual, 2021-12-31) — Investing Cash Flow: -43876.00
OGEN balance_sheet (annual, 2021-12-31) — Leases: 487871.00
OGEN balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 299520.00
OGEN balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 299520.00
OGEN balance_sheet (annual, 2021-12-31) — Machinery Furniture Equipment: 314978.00
OGEN balance_sheet (annual, 2021-12-31) — Net PPE: 523590.00
OGEN cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: -43876.00
OGEN cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: -5635672.00
OGEN income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 670.00
OGEN income_statement (annual, 2021-12-31) — Other Operating Expenses: -86987.00
OGEN balance_sheet (annual, 2021-12-31) — Other Properties: 1347537.00
OGEN balance_sheet (annual, 2021-12-31) — Other Receivables: 6987.00
OGEN income_statement (annual, 2021-12-31) — Other Taxes: 1357.00
OGEN balance_sheet (annual, 2021-12-31) — Payables: 854983.00
OGEN balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 57731.00
OGEN balance_sheet (annual, 2021-12-31) — Preferred Stock Equity: 2656713.00
OGEN cash_flow (annual, 2021-12-31) — Preferred Stock Payments: -5635672.00
OGEN balance_sheet (annual, 2021-12-31) — Prepaid Assets: 434699.00
OGEN cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 2624476.00
OGEN balance_sheet (annual, 2021-12-31) — Properties: 0.00
OGEN cash_flow (annual, 2021-12-31) — Purchase Of PPE: -43876.00
OGEN balance_sheet (annual, 2021-12-31) — Receivables: 6987.00
OGEN income_statement (annual, 2021-12-31) — Reconciled Depreciation: 41237.00
OGEN cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: -5635672.00
OGEN cash_flow (annual, 2021-12-31) — Sale Of PPE: 0.00
OGEN income_statement (annual, 2022-12-31) — +Operating Expense: 14420768.00
OGEN income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
OGEN balance_sheet (annual, 2022-12-31) — Accounts Payable: 246690.00
OGEN balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1363239.00
OGEN balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 196977071.00
OGEN income_statement (annual, 2022-12-31) — Basic Average Shares: 66974.00
OGEN income_statement (annual, 2022-12-31) — Basic EPS: -213.30
OGEN cash_flow (annual, 2022-12-31) — Beginning Cash Position: 27265703.00
OGEN cash_flow (annual, 2022-12-31) — Capital Expenditure: -127519.00
OGEN balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 356886.00
OGEN balance_sheet (annual, 2022-12-31) — Capital Stock: 1594748.00
OGEN balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 11426785.00
OGEN balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 11426785.00
OGEN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -494916.00
OGEN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -115519.00
OGEN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -15228483.00
OGEN cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 0.00
OGEN cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 176625.00
OGEN cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -1899612.00
OGEN cash_flow (annual, 2022-12-31) — Change In Receivables: 6987.00
OGEN cash_flow (annual, 2022-12-31) — Change In Working Capital: -1716000.00
OGEN cash_flow (annual, 2022-12-31) — Changes In Cash: -15838918.00
OGEN balance_sheet (annual, 2022-12-31) — Common Stock: 2025.00
OGEN balance_sheet (annual, 2022-12-31) — Common Stock Equity: 11416579.00
OGEN cash_flow (annual, 2022-12-31) — Common Stock Issuance: 69289.00
OGEN balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 843962.00
OGEN balance_sheet (annual, 2022-12-31) — Current Assets: 14289523.00
OGEN balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 204447.00
OGEN balance_sheet (annual, 2022-12-31) — Current Debt: 267640.00
OGEN balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 472087.00
OGEN balance_sheet (annual, 2022-12-31) — Current Liabilities: 1596284.00
OGEN balance_sheet (annual, 2022-12-31) — Current Notes Payable: 267640.00
OGEN cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 44667.00
OGEN cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 44667.00
OGEN income_statement (annual, 2022-12-31) — Diluted Average Shares: 66974.00
OGEN income_statement (annual, 2022-12-31) — Diluted EPS: -213.30
OGEN income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -14288389.00
OGEN income_statement (annual, 2022-12-31) — EBIT: -14273286.00
OGEN income_statement (annual, 2022-12-31) — EBITDA: -14228619.00
OGEN cash_flow (annual, 2022-12-31) — End Cash Position: 11426785.00
OGEN cash_flow (annual, 2022-12-31) — Financing Cash Flow: -494916.00
OGEN cash_flow (annual, 2022-12-31) — Free Cash Flow: -15356002.00
OGEN cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -10964.00
OGEN income_statement (annual, 2022-12-31) — General And Administrative Expense: 4479605.00
OGEN balance_sheet (annual, 2022-12-31) — Gross PPE: 1831741.00
OGEN income_statement (annual, 2022-12-31) — Interest Expense: 15103.00
OGEN income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 15103.00
OGEN income_statement (annual, 2022-12-31) — Interest Income: 135900.00
OGEN income_statement (annual, 2022-12-31) — Interest Income Non Operating: 135900.00
OGEN cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 9290.00
OGEN balance_sheet (annual, 2022-12-31) — Invested Capital: 11684219.00
OGEN cash_flow (annual, 2022-12-31) — Investing Cash Flow: -115519.00
OGEN cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 69289.00
OGEN cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
OGEN balance_sheet (annual, 2022-12-31) — Leases: 487871.00
OGEN balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 152439.00
OGEN balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 152439.00
OGEN balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 319686.00
OGEN cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 69289.00
OGEN income_statement (annual, 2022-12-31) — Net Income: -14288389.00
OGEN income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -14288389.00
OGEN income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -14288389.00
OGEN income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -14288389.00
OGEN income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -14288389.00
OGEN cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -14288389.00
OGEN income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -14288389.00
OGEN cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: 0.00
OGEN income_statement (annual, 2022-12-31) — Net Interest Income: 120797.00
OGEN cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -564205.00
OGEN income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 120797.00
OGEN balance_sheet (annual, 2022-12-31) — Net PPE: 468502.00
OGEN cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -115519.00
OGEN cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
OGEN cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -564205.00
OGEN balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 13009302.00
OGEN balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 0.00
OGEN income_statement (annual, 2022-12-31) — Normalized EBITDA: -14228619.00
OGEN income_statement (annual, 2022-12-31) — Normalized Income: -14288389.00
OGEN cash_flow (annual, 2022-12-31) — Operating Cash Flow: -15228483.00
OGEN cash_flow (annual, 2022-12-31) — Operating Gains Losses: -10964.00
OGEN income_statement (annual, 2022-12-31) — Operating Income: -14420768.00
OGEN income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
OGEN balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 67488.00
OGEN balance_sheet (annual, 2022-12-31) — Other Current Assets: 2862738.00
OGEN income_statement (annual, 2022-12-31) — Other Gand A: 4479605.00
OGEN income_statement (annual, 2022-12-31) — Other Income Expense: 11582.00
OGEN income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 11582.00
OGEN income_statement (annual, 2022-12-31) — Other Operating Expenses: -131521.00
OGEN balance_sheet (annual, 2022-12-31) — Other Properties: 1024184.00
OGEN income_statement (annual, 2022-12-31) — Other Taxes: 5140.00
OGEN balance_sheet (annual, 2022-12-31) — Payables: 246690.00
OGEN balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1090652.00
OGEN balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 33545.00
OGEN balance_sheet (annual, 2022-12-31) — Preferred Stock: 1592723.00
OGEN balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 1592723.00
OGEN cash_flow (annual, 2022-12-31) — Preferred Stock Payments: 0.00
OGEN balance_sheet (annual, 2022-12-31) — Prepaid Assets: 2862738.00
OGEN income_statement (annual, 2022-12-31) — Pretax Income: -14288389.00
OGEN cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
OGEN balance_sheet (annual, 2022-12-31) — Properties: 0.00
OGEN cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: 0.00
OGEN cash_flow (annual, 2022-12-31) — Purchase Of PPE: -127519.00
OGEN balance_sheet (annual, 2022-12-31) — Receivables: 0.00
OGEN income_statement (annual, 2022-12-31) — Reconciled Depreciation: 44667.00
OGEN cash_flow (annual, 2022-12-31) — Repayment Of Debt: -564205.00
OGEN cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
OGEN income_statement (annual, 2022-12-31) — Research And Development: 10072684.00
OGEN balance_sheet (annual, 2022-12-31) — Retained Earnings: -185562517.00
OGEN cash_flow (annual, 2022-12-31) — Sale Of PPE: 12000.00
OGEN income_statement (annual, 2022-12-31) — Selling General And Administration: 4479605.00
OGEN balance_sheet (annual, 2022-12-31) — Share Issued: 67488.00
OGEN cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
OGEN cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -564205.00
OGEN cash_flow (annual, 2022-12-31) — Stock Based Compensation: 742203.00
OGEN balance_sheet (annual, 2022-12-31) — Stockholders Equity: 13009302.00
OGEN balance_sheet (annual, 2022-12-31) — Tangible Book Value: 11416579.00
OGEN income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
OGEN income_statement (annual, 2022-12-31) — Tax Provision: 0.00
OGEN income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
OGEN balance_sheet (annual, 2022-12-31) — Total Assets: 14758025.00
OGEN balance_sheet (annual, 2022-12-31) — Total Capitalization: 13009302.00
OGEN balance_sheet (annual, 2022-12-31) — Total Debt: 624526.00
OGEN balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 13009302.00
OGEN income_statement (annual, 2022-12-31) — Total Expenses: 14420768.00
OGEN balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1748723.00
OGEN balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 468502.00
OGEN balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 152439.00
OGEN income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -14420768.00
OGEN balance_sheet (annual, 2022-12-31) — Working Capital: 12693239.00
OGEN income_statement (annual, 2023-12-31) — +Operating Expense: 20904903.00
OGEN income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
OGEN balance_sheet (annual, 2023-12-31) — Accounts Payable: 1244947.00
OGEN balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: 0.00
OGEN balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 207790604.00
OGEN income_statement (annual, 2023-12-31) — Basic Average Shares: 74989.00
OGEN income_statement (annual, 2023-12-31) — Basic EPS: -275.40
OGEN cash_flow (annual, 2023-12-31) — Beginning Cash Position: 11426785.00
OGEN cash_flow (annual, 2023-12-31) — Capital Expenditure: -1000000.00
OGEN balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 9811.00
OGEN balance_sheet (annual, 2023-12-31) — Capital Stock: 1595804.00
OGEN balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 3483501.00
OGEN balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 3483501.00
OGEN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 283880.00
OGEN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -936284.00
OGEN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -7290880.00
OGEN cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 337629.00
OGEN cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -347075.00
OGEN cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 25798.00
OGEN cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 2000824.00
OGEN cash_flow (annual, 2023-12-31) — Change In Receivables: 0.00
OGEN cash_flow (annual, 2023-12-31) — Change In Working Capital: 2017176.00
OGEN cash_flow (annual, 2023-12-31) — Changes In Cash: -7943284.00
OGEN balance_sheet (annual, 2023-12-31) — Common Stock: 3081.00
OGEN balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1575431.00
OGEN cash_flow (annual, 2023-12-31) — Common Stock Issuance: 849926.00
OGEN balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 222739.00
OGEN balance_sheet (annual, 2023-12-31) — Current Assets: 3865774.00
OGEN balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 9811.00
OGEN balance_sheet (annual, 2023-12-31) — Current Debt: 312703.00
OGEN balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 322514.00
OGEN balance_sheet (annual, 2023-12-31) — Current Liabilities: 1798181.00
OGEN balance_sheet (annual, 2023-12-31) — Current Notes Payable: 312703.00
OGEN cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 27391.00
OGEN cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 27391.00
OGEN income_statement (annual, 2023-12-31) — Diluted Average Shares: 74989.00
OGEN income_statement (annual, 2023-12-31) — Diluted EPS: -275.40
OGEN income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -20655737.00
OGEN income_statement (annual, 2023-12-31) — EBIT: -20625146.00
OGEN income_statement (annual, 2023-12-31) — EBITDA: -20597755.00
OGEN cash_flow (annual, 2023-12-31) — End Cash Position: 3483501.00
OGEN cash_flow (annual, 2023-12-31) — Financing Cash Flow: 283880.00
OGEN cash_flow (annual, 2023-12-31) — Free Cash Flow: -8290880.00
OGEN cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 29956.00
OGEN income_statement (annual, 2023-12-31) — General And Administrative Expense: 5451952.00
OGEN balance_sheet (annual, 2023-12-31) — Gross PPE: 9811.00
OGEN income_statement (annual, 2023-12-31) — Interest Expense: 30591.00
OGEN income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 30591.00
OGEN income_statement (annual, 2023-12-31) — Interest Income: 210394.00
OGEN income_statement (annual, 2023-12-31) — Interest Income Non Operating: 210394.00
OGEN cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 30591.00
OGEN balance_sheet (annual, 2023-12-31) — Invested Capital: 1888134.00
OGEN cash_flow (annual, 2023-12-31) — Investing Cash Flow: -936284.00
OGEN cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 849926.00
OGEN cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
OGEN balance_sheet (annual, 2023-12-31) — Leases: 0.00
OGEN balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 0.00
OGEN balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
OGEN balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 0.00
OGEN cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 849926.00
OGEN income_statement (annual, 2023-12-31) — Net Income: -20655737.00
OGEN income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -20655737.00
OGEN income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -20655737.00
OGEN income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -20655737.00
OGEN income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -20655737.00
OGEN cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -20655737.00
OGEN income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -20655737.00
OGEN cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -1000000.00
OGEN income_statement (annual, 2023-12-31) — Net Interest Income: 179803.00
OGEN cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -566046.00
OGEN income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 179803.00
OGEN balance_sheet (annual, 2023-12-31) — Net PPE: 9811.00
OGEN cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 63716.00
OGEN cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -566046.00
OGEN balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 3168154.00
OGEN balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 1090750.00
OGEN income_statement (annual, 2023-12-31) — Normalized EBITDA: -20597755.00
OGEN income_statement (annual, 2023-12-31) — Normalized Income: -20655737.00
OGEN cash_flow (annual, 2023-12-31) — Operating Cash Flow: -7290880.00
OGEN cash_flow (annual, 2023-12-31) — Operating Gains Losses: 29956.00
OGEN income_statement (annual, 2023-12-31) — Operating Income: -20904903.00
OGEN income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
OGEN balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 102689.00
OGEN balance_sheet (annual, 2023-12-31) — Other Current Assets: 382273.00
OGEN income_statement (annual, 2023-12-31) — Other Gand A: 5451952.00
OGEN income_statement (annual, 2023-12-31) — Other Income Expense: 69363.00
OGEN cash_flow (annual, 2023-12-31) — Other Non Cash Items: 10273506.00
OGEN income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 69363.00
OGEN income_statement (annual, 2023-12-31) — Other Operating Expenses: -37653.00
OGEN balance_sheet (annual, 2023-12-31) — Other Properties: 9811.00
OGEN balance_sheet (annual, 2023-12-31) — Payables: 1244947.00
OGEN balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1467686.00
OGEN balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 7981.00
OGEN balance_sheet (annual, 2023-12-31) — Preferred Stock: 1592723.00
OGEN balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 1592723.00
OGEN income_statement (annual, 2023-12-31) — Pretax Income: -20655737.00
OGEN balance_sheet (annual, 2023-12-31) — Properties: 0.00
OGEN cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -1000000.00
OGEN cash_flow (annual, 2023-12-31) — Purchase Of PPE: 0.00
OGEN income_statement (annual, 2023-12-31) — Reconciled Depreciation: 27391.00
OGEN cash_flow (annual, 2023-12-31) — Repayment Of Debt: -566046.00
OGEN income_statement (annual, 2023-12-31) — Research And Development: 15490604.00
OGEN balance_sheet (annual, 2023-12-31) — Retained Earnings: -206218254.00
OGEN cash_flow (annual, 2023-12-31) — Sale Of PPE: 63716.00
OGEN income_statement (annual, 2023-12-31) — Selling General And Administration: 5451952.00
OGEN balance_sheet (annual, 2023-12-31) — Share Issued: 102689.00
OGEN cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 0.00
OGEN cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -566046.00
OGEN cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1016828.00
OGEN balance_sheet (annual, 2023-12-31) — Stockholders Equity: 3168154.00
OGEN balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1575431.00
OGEN income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
OGEN income_statement (annual, 2023-12-31) — Tax Provision: 0.00
OGEN income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
OGEN balance_sheet (annual, 2023-12-31) — Total Assets: 4966335.00
OGEN balance_sheet (annual, 2023-12-31) — Total Capitalization: 3168154.00
OGEN balance_sheet (annual, 2023-12-31) — Total Debt: 322514.00
OGEN balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 3168154.00
OGEN income_statement (annual, 2023-12-31) — Total Expenses: 20904903.00
OGEN balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1798181.00
OGEN balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1100561.00
OGEN balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
OGEN income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -20904903.00
OGEN balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
OGEN balance_sheet (annual, 2023-12-31) — Working Capital: 2067593.00
OGEN balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 1513287.00
OGEN income_statement (quarterly, 2024-09-30) — Basic Average Shares: 217602.00
OGEN income_statement (quarterly, 2024-09-30) — Basic EPS: -11.32
OGEN balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 0.00
OGEN cash_flow (quarterly, 2024-09-30) — Change In Receivables: 0.00
OGEN balance_sheet (quarterly, 2024-09-30) — Current Accrued Expenses: 65657.00
OGEN balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 0.00
OGEN balance_sheet (quarterly, 2024-09-30) — Current Notes Payable: 519392.00
OGEN cash_flow (quarterly, 2024-09-30) — Depreciation Amortization Depletion: 0.00
OGEN cash_flow (quarterly, 2024-09-30) — Depreciation And Amortization: 0.00
OGEN income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 217602.00
OGEN income_statement (quarterly, 2024-09-30) — Diluted EPS: -11.32
OGEN balance_sheet (quarterly, 2024-09-30) — Gross PPE: 0.00
OGEN balance_sheet (quarterly, 2024-09-30) — Net PPE: 0.00
OGEN balance_sheet (quarterly, 2024-09-30) — Non Current Prepaid Assets: 1090750.00
OGEN balance_sheet (quarterly, 2024-09-30) — Payables: 1513287.00
OGEN balance_sheet (quarterly, 2024-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 28170.00
OGEN balance_sheet (quarterly, 2024-09-30) — Preferred Stock Equity: 1592723.00
OGEN income_statement (quarterly, 2024-09-30) — Reconciled Depreciation: 0.00
OGEN income_statement (quarterly, 2024-09-30) — Tax Provision: 0.00
OGEN income_statement (annual, 2024-12-31) — +Operating Expense: 10558815.00
OGEN income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
OGEN balance_sheet (annual, 2024-12-31) — Accounts Payable: 1144634.00
OGEN balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 1144634.00
OGEN balance_sheet (annual, 2024-12-31) — Accrued Interest Receivable: 0.00
OGEN balance_sheet (quarterly, 2024-12-31) — Accrued Interest Receivable: 0.00
OGEN balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 216573868.00
OGEN income_statement (annual, 2024-12-31) — Basic Average Shares: 220731.00
OGEN income_statement (annual, 2024-12-31) — Basic EPS: -47.88
OGEN cash_flow (annual, 2024-12-31) — Beginning Cash Position: 3483501.00
OGEN balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 0.00
OGEN balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 0.00
OGEN balance_sheet (annual, 2024-12-31) — Capital Stock: 419.00
OGEN balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 864840.00
OGEN balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 864840.00
OGEN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 5978721.00
OGEN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 0.00
OGEN cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: 0.00
OGEN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -8597382.00
OGEN cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 9811.00
OGEN cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: 0.00
OGEN cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -9811.00
OGEN cash_flow (quarterly, 2024-12-31) — Change In Other Current Liabilities: 0.00
OGEN cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -119800.00
OGEN cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 1574287.00
OGEN cash_flow (annual, 2024-12-31) — Change In Receivables: 0.00
OGEN cash_flow (annual, 2024-12-31) — Change In Working Capital: 1454487.00
OGEN cash_flow (annual, 2024-12-31) — Changes In Cash: -2618661.00
OGEN balance_sheet (annual, 2024-12-31) — Common Stock: 419.00
OGEN balance_sheet (annual, 2024-12-31) — Common Stock Equity: -211885.00
OGEN cash_flow (annual, 2024-12-31) — Common Stock Issuance: 6671830.00
OGEN balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 202834.00
OGEN balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 202834.00
OGEN balance_sheet (annual, 2024-12-31) — Current Assets: 1472510.00
OGEN balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 0.00
OGEN balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 0.00
OGEN balance_sheet (annual, 2024-12-31) — Current Debt: 328528.00
OGEN balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 328528.00
OGEN balance_sheet (annual, 2024-12-31) — Current Liabilities: 1684395.00
OGEN balance_sheet (annual, 2024-12-31) — Current Notes Payable: 328528.00
OGEN balance_sheet (quarterly, 2024-12-31) — Current Notes Payable: 328528.00
OGEN cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 0.00
OGEN cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 0.00
OGEN cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 0.00
OGEN cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 0.00
OGEN income_statement (annual, 2024-12-31) — Diluted Average Shares: 220731.00
OGEN income_statement (annual, 2024-12-31) — Diluted EPS: -47.88
OGEN income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -10567918.00
OGEN income_statement (annual, 2024-12-31) — EBIT: -10538090.00
OGEN income_statement (annual, 2024-12-31) — EBITDA: -10538090.00
OGEN cash_flow (annual, 2024-12-31) — End Cash Position: 864840.00
OGEN cash_flow (annual, 2024-12-31) — Financing Cash Flow: 5978721.00
OGEN cash_flow (annual, 2024-12-31) — Free Cash Flow: -8597382.00
OGEN cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
OGEN cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
OGEN income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -25172.00
OGEN income_statement (annual, 2024-12-31) — General And Administrative Expense: 6444381.00
OGEN balance_sheet (annual, 2024-12-31) — Gross PPE: 0.00
OGEN balance_sheet (quarterly, 2024-12-31) — Gross PPE: 0.00
OGEN income_statement (annual, 2024-12-31) — Interest Expense: 29828.00
OGEN income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 29828.00
OGEN income_statement (annual, 2024-12-31) — Interest Income: 45897.00
OGEN income_statement (annual, 2024-12-31) — Interest Income Non Operating: 45897.00
OGEN cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 29828.00
OGEN balance_sheet (annual, 2024-12-31) — Invested Capital: 116643.00
OGEN cash_flow (annual, 2024-12-31) — Investing Cash Flow: 0.00
OGEN cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: 0.00
OGEN cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 6671830.00
OGEN cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
OGEN cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 6671830.00
OGEN income_statement (annual, 2024-12-31) — Net Income: -10567918.00
OGEN income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -10567918.00
OGEN income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -10567918.00
OGEN income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -10567918.00
OGEN income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -10567918.00
OGEN cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -10567918.00
OGEN income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -10567918.00
OGEN cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
OGEN income_statement (annual, 2024-12-31) — Net Interest Income: 16069.00
OGEN cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -693109.00
OGEN income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 16069.00
OGEN balance_sheet (annual, 2024-12-31) — Net PPE: 0.00
OGEN balance_sheet (quarterly, 2024-12-31) — Net PPE: 0.00
OGEN cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 0.00
OGEN cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: 0.00
OGEN cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
OGEN cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -693109.00
OGEN balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -211885.00
OGEN balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 0.00
OGEN balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 0.00
OGEN income_statement (annual, 2024-12-31) — Normalized EBITDA: -10512918.00
OGEN income_statement (annual, 2024-12-31) — Normalized Income: -10542746.00
OGEN cash_flow (annual, 2024-12-31) — Operating Cash Flow: -8597382.00
OGEN income_statement (annual, 2024-12-31) — Operating Income: -10558815.00
OGEN income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
OGEN balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 419003.00
OGEN balance_sheet (annual, 2024-12-31) — Other Current Assets: 607670.00
OGEN income_statement (annual, 2024-12-31) — Other Gand A: 6444381.00
OGEN income_statement (annual, 2024-12-31) — Other Income Expense: -25172.00
OGEN balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 0.00
OGEN balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 0.00
OGEN balance_sheet (annual, 2024-12-31) — Payables: 1144634.00
OGEN balance_sheet (quarterly, 2024-12-31) — Payables: 1144634.00
OGEN balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 1355867.00
OGEN balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 8399.00
OGEN balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 8399.00
OGEN balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
OGEN cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
OGEN income_statement (annual, 2024-12-31) — Pretax Income: -10567918.00
OGEN cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
OGEN balance_sheet (annual, 2024-12-31) — Receivables: 0.00
OGEN balance_sheet (quarterly, 2024-12-31) — Receivables: 0.00
OGEN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 0.00
OGEN income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 0.00
OGEN cash_flow (annual, 2024-12-31) — Repayment Of Debt: -693109.00
OGEN income_statement (annual, 2024-12-31) — Research And Development: 4114434.00
OGEN balance_sheet (annual, 2024-12-31) — Retained Earnings: -216786172.00
OGEN cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
OGEN cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
OGEN income_statement (annual, 2024-12-31) — Selling General And Administration: 6444381.00
OGEN balance_sheet (annual, 2024-12-31) — Share Issued: 419003.00
OGEN cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 0.00
OGEN cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -693109.00
OGEN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 516049.00
OGEN balance_sheet (annual, 2024-12-31) — Stockholders Equity: -211885.00
OGEN balance_sheet (annual, 2024-12-31) — Tangible Book Value: -211885.00
OGEN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
OGEN income_statement (annual, 2024-12-31) — Tax Provision: 0.00
OGEN income_statement (quarterly, 2024-12-31) — Tax Provision: 0.00
OGEN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
OGEN balance_sheet (annual, 2024-12-31) — Total Assets: 1472510.00
OGEN balance_sheet (annual, 2024-12-31) — Total Capitalization: -211885.00
OGEN balance_sheet (annual, 2024-12-31) — Total Debt: 328528.00
OGEN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -211885.00
OGEN income_statement (annual, 2024-12-31) — Total Expenses: 10558815.00
OGEN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1684395.00
OGEN balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 0.00
OGEN balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
OGEN income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -10558815.00
OGEN income_statement (annual, 2024-12-31) — Total Unusual Items: -25172.00
OGEN income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -25172.00
OGEN balance_sheet (annual, 2024-12-31) — Working Capital: -211885.00
OGEN income_statement (quarterly, 2025-03-31) — +Operating Expense: 2026227.00
OGEN income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
OGEN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 772498.00
OGEN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 219119378.00
OGEN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 18216240.00
OGEN income_statement (quarterly, 2025-03-31) — Basic EPS: -0.12
OGEN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 864840.00
OGEN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 21475.00
OGEN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 3421078.00
OGEN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 3421078.00
OGEN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 4668328.00
OGEN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 0.00
OGEN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -2112090.00
OGEN cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 0.00
OGEN cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 0.00
OGEN cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -178829.00
OGEN cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 159637.00
OGEN cash_flow (quarterly, 2025-03-31) — Change In Receivables: 0.00
OGEN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -19192.00
OGEN cash_flow (quarterly, 2025-03-31) — Changes In Cash: 2556238.00
OGEN balance_sheet (quarterly, 2025-03-31) — Common Stock: 21475.00
OGEN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 137688.00
OGEN cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 2635330.00
OGEN balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 398434.00
OGEN balance_sheet (quarterly, 2025-03-31) — Current Assets: 3869111.00
OGEN balance_sheet (quarterly, 2025-03-31) — Current Debt: 2554385.00
OGEN balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 2554385.00
OGEN balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 3731423.00
OGEN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 18216240.00
OGEN income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.12
OGEN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -2216993.00
OGEN income_statement (quarterly, 2025-03-31) — EBIT: -2017866.00
OGEN income_statement (quarterly, 2025-03-31) — EBITDA: -2017866.00
OGEN cash_flow (quarterly, 2025-03-31) — End Cash Position: 3421078.00
OGEN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 4668328.00
OGEN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -2112090.00
OGEN income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -1842.00
OGEN income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1684685.00
OGEN income_statement (quarterly, 2025-03-31) — Interest Expense: 199127.00
OGEN income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 199127.00
OGEN income_statement (quarterly, 2025-03-31) — Interest Income: 10203.00
OGEN income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 10203.00
OGEN cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 6268.00
OGEN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 2692073.00
OGEN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 0.00
OGEN cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 2635330.00
OGEN cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 2228563.00
OGEN cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 2635330.00
OGEN income_statement (quarterly, 2025-03-31) — Net Income: -2216993.00
OGEN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -2216993.00
OGEN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -2216993.00
OGEN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -2216993.00
OGEN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -2216993.00
OGEN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -2216993.00
OGEN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -2216993.00
OGEN income_statement (quarterly, 2025-03-31) — Net Interest Income: -188924.00
OGEN cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
OGEN cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 2032998.00
OGEN income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -188924.00
OGEN cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 2032998.00
OGEN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 137688.00
OGEN income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -2016024.00
OGEN income_statement (quarterly, 2025-03-31) — Normalized Income: -2215151.00
OGEN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -2112090.00
OGEN income_statement (quarterly, 2025-03-31) — Operating Income: -2026227.00
OGEN income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
OGEN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 715842.00
OGEN balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 62673.00
OGEN balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 2554385.00
OGEN income_statement (quarterly, 2025-03-31) — Other Gand A: 1684685.00
OGEN income_statement (quarterly, 2025-03-31) — Other Income Expense: -1842.00
OGEN cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 192859.00